The rapid progress in the elucidation of antibody structure and function had a major impact on our understanding of monoclonal immunoglobulins. It appears that monoclonicity is a basic immunologic phenomenon, closely related to specificity. The amplification of this phenomenon, observed in pathological conditions such as the various plasma cell dyscrasias, has not been fully understood due to the lack of identifiable antigens capable of triggering this response. The functional and structural data accumulated from animal experiments and the clinical investigation of anti-dextran, anti-phosphorylcholine, anti-thioflavine and homogeneous anti-arsonate antibodies as well as of cold agglutinins., point to the presence of a common structure/function relationship in these molecules. Structural and serologic data, obtained from homogeneous antibodies isolated by us from the serum of patients with cancer of the colon and of the urinary bladder, revealed significant structural similarities expressed by HVR homology and cross-idiotypic specificity.

Keywords:
Structure/function relationship, Monoclonicity, Homogeneous antibodies, Plasma cell dyscrasia, Hypervariable regions, Idiotypic specificity
This content is only available via PDF.
© 1982 S. Karger AG, Basel
1982
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.